Influenza Vaccines
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SHOP-OY-24-000810
- Agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Place of performance
- Quantico, Virginia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Federal Bureau of Investigation (FBI) Human Resources Division (HRD) has published a Special Notice for the procurement of quadrivalent influenza vaccines. The FBI intends to negotiate a one-time, firm fixed price contract with GlaxoSmithKline, LLC. for up to 14,000 vaccines.
The purpose of this Special Notice is to provide information about the FBI's requirement for the influenza vaccines and to invite interested parties to identify their interest and submit a capabilities statement. The deadline for submitting a response is June 18, 2024, by 12:00 pm EST. The FBI has determined that GlaxoSmithKline, LLC. is the only source capable of providing the vaccines due to the specific packaging and cold chain requirements. Interested parties must be registered in the System for Award Management (SAM) and provide an OEM Authorized Reseller letter or certificate to be considered. The government reserves the right to determine whether to proceed with the proposed contract based on the responses received.
Notice text
PLEASE READ THIS NOTICE CAREFULLY AS IT CONSTITUTES THE ONLY NOTICE THAT WILL BE PUBLISHED.
The Federal Bureau of Investigation (FBI) Human Resources Division (HRD) intends to negotiate a one-time, firm fixed price contract, with GlaxoSmithKline, LLC., located at 410 Blackwell ST, Durham, North Carolina 27701-3986, United States for quadrivalent influenza vaccines. The vaccines identified meets the HRD’s specific mission requirements. GlaxoSmithKline, LLC. has been identified as the only source capable of supplying the vaccines (up to 14,000) as the identified vendor can supply the vaccines in the required packaging of (Individual boxes of 10 (ten) prefilled syringes, individual boxes are to be no larger than 6.92’’ x 1.14’’ x 3.95’’), this is the required packaging size as no other size unit will allow for the vaccines to fit in the refrigeration units at the FBI facilities. The identified vendor also complies with the required cold chain packaging Centers for Disease Control (CDC) guidelines. This cold chain requirement includes a temperature monitoring device that indicates cold chain excursions included in the shipping containers used to ship the vaccines. The identified vendor can also meet the shipping requirement to ship the vaccines (up to 14,000) to sixty (60) different FBI locations within ninety (90) days After Recipt of Order (ARO).
In conclusion, based on market research, Government end-users, and speaking with the manufacturer, it has been determined the FBI's requirement can only be provided GlaxoSmithKline, LLC., as no other vendor can provide the requested products. Justification available upon request.
This notice will be distributed solely through the General Services Administration’s System for Awards Management website (www.SAM.gov). Interested parties are responsible for monitoring the site to ensure they have the most up-to-date information about this acquisition.
The Government intends to negotiate with only one source under the authority of FAR 6.302-1. This notice of intent is not a request for competitive quotations; however, interested parties may identify their interests and submit a capabilities statement to include an OEM Authorized Reseller letter or certificate in response to this requirement to Contracting Officer Emma Taylor Reynolds via email at etreynolds@fbi.gov, no later than 12:00 pm EST on Tuesday, June 18th, 2024. Responses sent utilizing other means (i.e., via a telephone call, facsimile transmission, etc.) will not be considered. Information received will be used solely to determine whether to conduct a competitive procurement. A determination by the Government not to complete this proposed contract based upon responses to this notice is at the discretion of the Government.
Vendors must be registered in SAM, effective July 29, 2012, to receive government contracts. The FBI uses a financial system that has a direct interface with SAM. Please ensure that your company’s SAM information is updated and accurate. This includes TIN, EFT, UEI, addresses and contact information. The EFT banking information on file in SAM will be what the FBI uses to process payment to your organization.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Influenza Vaccines | Award Notice | |
| This notice | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity